Skip to main content
Top
Published in: Dermatology and Therapy 1/2021

Open Access 01-02-2021 | Probiotics | Review

Topical Probiotics in Dermatological Therapy and Skincare: A Concise Review

Author: Katlein França

Published in: Dermatology and Therapy | Issue 1/2021

Login to get access

Abstract

Recent studies have produced an increasing body of evidence that the intestinal microbiome plays an essential role in modulating systemic inflammation and skin diseases. The gut microbiome influences and modulates the host immune system, enabling immune tolerance of environmental and dietary antigens and protecting against pathogens. Emerging scientific evidence has demonstrated that oral probiotics can help treat certain skin diseases, such as acne, atopic dermatitis, photoaging, psoriasis, and wound healing. The aim of this paper is to review the current scientific evidence on topical probiotics and their effects on dermatological diseases and skincare and to clarify if the application of exogenous probiotics could also have the same benefit as oral probiotics in promoting positive bacterial balance to treat dermatologic conditions.
Literature
4.
go back to reference Lee GR, Maarouf M, Hendricks AJ, Lee DE, Shi VY. Topical probiotics: the unknowns behind their rising popularity. Dermatol Online J. 2019;25(5):13030/qt2v83r5wk. Lee GR, Maarouf M, Hendricks AJ, Lee DE, Shi VY. Topical probiotics: the unknowns behind their rising popularity. Dermatol Online J. 2019;25(5):13030/qt2v83r5wk.
9.
go back to reference Peyri J. Topical bacteriotherapy of the skin. J Cutaneous Dis. 1912;30:688–9. Peyri J. Topical bacteriotherapy of the skin. J Cutaneous Dis. 1912;30:688–9.
16.
go back to reference Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ. Inhibition of Propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. J Drugs Dermatol. 2006;5:868–70.PubMedPubMedCentral Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ. Inhibition of Propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. J Drugs Dermatol. 2006;5:868–70.PubMedPubMedCentral
21.
go back to reference Di Marzio L, Centi C, Cinque B, et al. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp Dermatol. 2003;12:615–20.CrossRef Di Marzio L, Centi C, Cinque B, et al. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp Dermatol. 2003;12:615–20.CrossRef
23.
go back to reference Lanchet-Réthoré S, Bourdès V, Mercenier A, Haddar CH, Verhoeven PO, Andres P. Effect of a lotion containing the heat-treated probiotic strain Lactobacillus johnsonii NCC 533 on Staphylococcus aureus colonization in atopic dermatitis. Clin Cosmet Investig Dermatol. 2017;10:249–57. https://doi.org/10.2147/CCID.S135529.CrossRef Lanchet-Réthoré S, Bourdès V, Mercenier A, Haddar CH, Verhoeven PO, Andres P. Effect of a lotion containing the heat-treated probiotic strain Lactobacillus johnsonii NCC 533 on Staphylococcus aureus colonization in atopic dermatitis. Clin Cosmet Investig Dermatol. 2017;10:249–57. https://​doi.​org/​10.​2147/​CCID.​S135529.CrossRef
25.
go back to reference Sharma D, Kober MM, Bowe WP. Anti-aging effects of probiotics. J Drugs Dermatol. 2016;15(1):9–12.PubMed Sharma D, Kober MM, Bowe WP. Anti-aging effects of probiotics. J Drugs Dermatol. 2016;15(1):9–12.PubMed
27.
Metadata
Title
Topical Probiotics in Dermatological Therapy and Skincare: A Concise Review
Author
Katlein França
Publication date
01-02-2021
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 1/2021
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-020-00476-7

Other articles of this Issue 1/2021

Dermatology and Therapy 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.